Dr. Mohammad Zovar, the representative of the Deputy for Knowledge-Based Companies Development, emphasized: "Emerging technologies like artificial intelligence are driving profound transformations across all industries, particularly in medicine and healthcare. Given the extraordinary potential of AI to advance our national healthcare system, the Deputy for Knowledge-Based Companies Development is committed to supporting and collaborating with the 'Second International Congress on Artificial Intelligence in Medical Sciences.' As a key supportive institution, we see this congress as an important step toward fostering innovation and progress in the health sector."
He emphasized that this collaboration aligns with the mission of the Deputy for Knowledge-Based Companies Development and added:
"Our aim is to support the development of modern technologies and facilitate interactions between technologists and specialists. To this end, several initiatives have been planned for the congress, including holding specialized meetings and workshops focused on evaluation processes and accessing support for knowledge-based companies. These workshops will provide valuable opportunities to introduce and explain the existing support mechanisms and operational processes available to companies and technologists in this field."
Dr. Zovar further noted:
"Additionally, we intend to use the official and media platforms affiliated with the Deputy for Knowledge-Based Companies Development to deliver comprehensive and accurate information to the scientific and technological communities. This will include introducing speakers, promoting programs, and disseminating news related to the congress via social media and other official channels."
Participation of Knowledge-Based Companies' Experts at the Second International Congress on Artificial Intelligence to Strengthen Collaboration in the AI Sector
The head of Data Monitoring and Analysis for Knowledge-Based Companies added:
"Another major initiative by the Deputy for Knowledge-Based Companies Development for engaging with the 'Second International Congress on Artificial Intelligence in Medical Sciences' is to create direct interaction opportunities. Therefore, experts from our office will be present at the event to engage directly with companies and technologists working in the AI and medical sciences fields."
He continued:
"The exhibition space of the congress will provide a valuable platform for showcasing innovators' achievements and enabling discussions and exchanges of ideas. These interactions can foster partnerships and accelerate the advancement of emerging technologies."
Enhancing Research Quality and Improving Commercialization and Practical Application of Knowledge in the Healthcare System
Dr. Zovar, referring to the Deputy’s collaboration with scientific and technological congresses, particularly in fields like AI in medicine, stated: "This cooperation contributes significantly to improving the quality of research and enhancing the processes of commercializing and applying knowledge within the healthcare system."
"It also opens up new opportunities for knowledge-based companies. At the Deputy for Knowledge-Based Companies Development, we are continuously working to accelerate the commercialization of technologies and support the growth and advancement of companies."
The representative further emphasized: "Such congresses act as bridges, facilitating connections between technologists, researchers, and policymakers, thereby paving the way for further innovation in various medical and health fields."
In conclusion, he invited all AI and healthcare sector professionals to participate in this scientific event, stating: "We hope the active participation of experts in the 'Second International Congress on Artificial Intelligence in Medical Sciences' will help drive positive transformations in the country’s healthcare sector. This congress represents a golden opportunity to accelerate scientific and technological innovations and collaborations."
